This institutional T-32 training grant (RR07073) proposal seeks funds to continue an outstanding environment for veterinarians (DVM or VMD) and DVM/PhDs to acquire specific research and conceptual skills to effectively utilize mouse models of human disease. Significant need exists for skilled scientists trained in modern translational research methods to apply advances in medicine to improve human health. The training program has enrolled 20 DVMs into the program since 2002 through outstanding recruitment and leverage of resources. Of the 20 trainees supported over the first 9 years of the program, 8 were awarded NIH K, TL1, or F Awards and 13 have matriculated and are employed in biomedical or academic positions and the remaining are on track to complete their training. All veterinarians recruited into the program have outstanding academic backgrounds and established records of research experiences. New training faculty and courses compliment experienced mentors who train veterinarian scientists in state-of-the-art molecular and cellular techniques to systematically evaluate the pathobiology of experimental mouse models of human disease important to public health. The training program is coordinated through The Ohio State University (OSU), College of Veterinary Medicine, Graduate Program in Comparative and Veterinary Medicine;an integral component of the most comprehensive health sciences center in America.
The Specific Aims of the training program include: 1) trainees will gain knowledge and skills to fully understand and evaluate pathophysiologic alterations of murine models of human disease through both didactic coursework and applied training in pathology and molecular biology;2) trainees will interact with our multidisciplinary faculty to identify the rane of research problems that use murine and other rodent models;3) trainees will acquaint themselves with the ongoing basic and clinical research studies in the laboratories and clinical sites of the participating faculty, and select a research problem that utilizes a murine or rodent model for endpoint evaluation;and 4) following the selection of a preceptor and research problem, trainees will participate in the design and performance of experiments, as well as analysis and presentation of data.
These specific aims support the overall goal of the T-32 Program to support trainees to acquire a broad background in molecular biology, genetics, pathology, laboratory animal medicine, and research design methodology. Training faculty represent an experienced group of basic and clinical scientists with strong training records from collaborative programs in multiple departments at OSU and Nationwide Children's Hospital. As a result of this training program, trainees will gain a comprehensive understanding of hypothesis-based research and gain knowledge and skills required to fulfill national needs in the development of skilled scientists in mouse pathobiology relevant to human health.
Significant need exists for skilled scientists trained in modern translational research methods to apply advances in medicine to improve human health. This institutional T-32 training grant proposal seeks funds to continue an outstanding environment for veterinarians to acquire specific research and conceptual skills to effectively utilize models of human disease to fulfill national needs for skilled scientists dedicated to improving human health.
|Henderson, Sally E; Makhijani, Neil; Mace, Thomas A (2018) Pancreatic Cancer-Induced Cachexia and Relevant Mouse Models. Pancreas 47:937-945|
|Kohnken, Rebecca; Wen, Jing; Mundy-Bosse, Bethany et al. (2018) Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma. Blood 131:771-781|
|Kohart, Nicole A; Elshafae, Said M; Breitbach, Justin T et al. (2017) Animal Models of Cancer-Associated Hypercalcemia. Vet Sci 4:|
|Kohnken, Rebecca; Kodigepalli, Karthik M; Mishra, Anjali et al. (2017) MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients. Leuk Res 52:58-66|
|Esser, Alison K; Rauch, Daniel A; Xiang, Jingyu et al. (2017) HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice. Oncotarget 8:69250-69263|
|Pepper, Victoria K; Clark, Elizabeth S; Best, Cameron A et al. (2017) Intravascular Ultrasound Characterization of a Tissue-Engineered Vascular Graft in an Ovine Model. J Cardiovasc Transl Res 10:128-138|
|Schrock, M S; Batar, B; Lee, J et al. (2017) Wwox-Brca1 interaction: role in DNA repair pathway choice. Oncogene 36:2215-2227|
|Himmel, Lauren E; Lustberg, Maryam B; DeVries, A Courtney et al. (2016) Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer. Exp Toxicol Pathol 68:505-515|
|Henderson, Sally E; Ding, Li-Yun; Mo, Xiaokui et al. (2016) Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42. Neoplasia 18:765-774|
|Clark, Elizabeth S; Best, Cameron; Onwuka, Ekene et al. (2016) Effect of cell seeding on neotissue formation in a tissue engineered trachea. J Pediatr Surg 51:49-55|
Showing the most recent 10 out of 19 publications